- Home
- GNS vs DYAI Comparison
GNS vs DYAI Comparison
Compare GNS & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNS | DYAI |
|---|---|---|
| Founded | 2002 | 1979 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.1M | 32.5M |
| IPO Year | 2021 | 2003 |
Fundamental Metrics
Financial Performance| Metric | GNS | DYAI |
|---|---|---|
| Price | $0.18 | $0.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 2.8M | 150.9K |
| Earning Date | 03-09-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,090,345.00 |
| Revenue This Year | $156.26 | $122.79 |
| Revenue Next Year | $35.38 | $100.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.15 | $0.62 |
| 52 Week High | $1.28 | $1.60 |
Technical Indicators
Market Signals| Indicator | GNS | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 63.72 | 29.73 |
| Support Level | $0.15 | N/A |
| Resistance Level | $0.23 | $0.90 |
| Average True Range (ATR) | 0.01 | 0.07 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 91.62 | 2.14 |
Price Performance
Historical ComparisonAbout GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. Its revenue is derived from five reportable segments: Central, Academy, School, Resorts, and Discontinued operations. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.